Olfr713, a member of the olfactory receptor family 10 subfamily A, holds a pivotal role in the intricate world of olfaction in Mus musculus. These olfactory receptors, characterized by their classic 7-transmembrane domain structure, belong to the vast family of G-protein-coupled receptors (GPCRs). Olfr713, like its fellow receptors, acts as a molecular sentinel in the nose, where it interacts with odorant molecules to initiate neuronal responses, ultimately leading to the perception of diverse scents. Turning our attention to Olfr713's inhibition, a story of indirect influence unfolds. While direct inhibitors remain elusive, a cadre of chemical agents emerges, each with the potential to subtly shape Olfr713's function. These inhibitors, such as YM-254890 and Gallein, influence the Gαq/11 protein and β-arrestin pathways, respectively, indirectly affecting olfactory signal transduction. U73122, a phospholipase C (PLC) inhibitor, may disrupt the PLC pathway crucial for olfactory signal transduction. The selective CaMKII inhibitor KN-93 fine-tunes calcium-dependent signaling pathways pivotal in olfaction, indirectly affecting Olfr713.
Wortmannin targets the PI3K/Akt pathway, associated with olfactory receptor signaling. SB203580 and PD 169316 focus on the MAPK pathway, potentially impacting Olfr713, which is associated with this pathway. H-89, a PKA inhibitor, might influence Olfr713 through PKA-mediated processes linked to olfaction. Xestospongin C, by modulating intracellular calcium signaling, could indirectly shape Olfr713's function. Cytosine Arabinoside, although unrelated to olfaction, might impact Olfr713 by affecting cellular processes in olfactory neurons. Lastly, Latrunculin A disrupts actin polymerization, crucial for olfaction, and Thapsigargin modulates intracellular calcium levels, playing a role in olfactory signaling. In the realm of Olfr713, where scent molecules orchestrate sensory symphonies, inhibition unveils itself as a narrative of subtle influence. While direct inhibitors remain elusive, these chemicals subtly shape the symphony of scent perception, each revealing a different facet of Olfr713's intricate role, promising to unveil the enigmatic mechanisms that govern olfactory receptors in the house mouse.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinases (PI3Ks), potentially affecting downstream signaling pathways related to Olfr713. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK1/2 inhibitor that can modulate the MAPK pathway, which may indirectly influence Olfr713 regulation. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker that can affect calcium signaling pathways, potentially impacting Olfr713 function. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
This inhibitor targets glycogen synthase kinase-3 (GSK-3), which can influence various signaling pathways related to Olfr713. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a calcium chelator that can reduce intracellular calcium levels, potentially affecting Olfr713-related processes. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
PTX inhibits G protein signaling, which could indirectly influence Olfr713 activity through GPCR-related pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin targets mTOR, a key protein in cellular processes, potentially affecting pathways associated with Olfr713. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB-203580 inhibits p38 MAPK, a kinase involved in stress response pathways that may intersect with Olfr713 regulation. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-glycosylation, which could indirectly impact Olfr713 by affecting protein maturation and trafficking. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A targets calcineurin and can influence calcium-dependent signaling, which may have downstream effects on Olfr713. | ||||||